1. European Medicines Agency, 2015, Xeloda capecitabine Product information, Xeloda: EPAR - Product Information, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000316/WC500058151.pdf, link accessed on 02.08.2016.
2. European Medicines Agency, 2015, Xeloda capecitabine Product information, Xeloda: EPAR summary for the public, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000316/WC500058146.pdf, link accessed on 02.08.2016.
3. Capecitabine: a review;Walko;Clin. Ther.,2005
4. Drug Bank Database, http://www.drugbank.ca/drugs/DB01101, link accessed on 02.08.2016.
5. The design and synthesis of a new tumor-selective fluoropyrimidine carbamate;Shimma;Capecitabine, Bioorgan. Med. Chem.,2000